GGrantIndex
Sort

59,101 grants matching hypertension

REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension

$761,805
Peter J Leary · University Of Washington · R61 · FY2023 · HL

The ARIC-PET Amyloid Imaging Study

$761,685
Rebecca F Gottesman · Johns Hopkins University · R01 · FY2016 · AG

COmuNity-engaged SimULation Training for Blood Pressure Control (CONSULT-BP)

$761,684
Jennifer Tjia · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · MD

Clinical and Biochemical Features of Metabolic Dysregulation in Formerly Preterm Children

$761,618
Eric Douglas Austin · Vanderbilt University Medical Center · R01 · FY2024 · HL

Conjugated bile acids as nutritionally re-programmable antihypertensive metabolites

$761,554
Bina Joe · University Of Toledo Health Sci Campus · R01 · FY2025 · HL

Randomized Clinical Trial of Nurse Family Partnership for Women with Previous Live Births

$761,518
Mandy Atlee Allison · University Of Colorado Denver · R01 · FY2023 · NR

MI-BP: mHealth to Improve Blood Pressure Control in Hypertensive African Americans

$761,420
Lorraine R Buis · University Of Michigan At Ann Arbor · R01 · FY2018 · HL

Early life stress and cardiometabolic health in adolescence

$761,358
Megan R Gunnar · University Of Minnesota · R01 · FY2020 · HL

Genetic Variants in Calcium Channel and Binding Proteins Underlying cIMT in HIV

$761,273
Sadeep Shrestha · University Of Alabama At Birmingham · R56 · FY2015 · HL

Automated clinic blood pressure assessment and detection of white coat and masked hypertension study in African Americans

$761,266
Marwah Abdalla · Columbia University Health Sciences · R01 · FY2021 · HL

Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline

$761,229
Jeffrey Murray Burns · University Of Kansas Medical Center · R61 · FY2020 · AG

Calcium Regulation in Heart Failure with Preserved versus Reduced Ejection Fraction

$761,174
Joshua I Goldhaber · Cedars-Sinai Medical Center · R01 · FY2019 · HL

mGlide RCT: A Clinical Glide Path to Close the Guideline-to-Practice Gap in HTN Management

$761,095
Kamakshi Lakshminarayan · University Of Minnesota · R01 · FY2019 · HL

Lipolysis during sleep and cardiometabolic consequences of sleep apnea

$761,077
Jonathan C. Jun · Johns Hopkins University · R01 · FY2022 · HL

Lipolysis during sleep and cardiometabolic consequences of sleep apnea

$761,077
Jonathan C. Jun · Johns Hopkins University · R01 · FY2020 · HL

Medial Arterial Calcification in Peripheral Artery Disease

$761,042
Cynthia St. Hilaire · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL

Prioritizing county-level social determinants that contribute to the greater burden of diabetes and hypertension in the US

$761,004
April P Carson · University Of Alabama At Birmingham · U01 · FY2019 · DP

Employing biologics to probe GPCR signaling in maternal and fetal health

$760,950
Meredith Anne Skiba · University Of Michigan At Ann Arbor · R00 · FY2025 · HD

Reducing Total Cardiovascular Risk in an Urban Community

$760,939
Jerilyn K Allen · Johns Hopkins University · R01 · FY2009 · HL

Air pollution and early signs of dementia

$760,906
Anke Huels · Emory University · R01 · FY2023 · AG

Nitric Oxide in Pulmonary Hypertension

$760,892
Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL

Multi-Omics for Maternal Health after Preeclampsia

$760,884
Louise Chang Laurent · University Of California, San Diego · U01 · FY2025 · HG

Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder

$760,878
Jennifer Beth Levin · Case Western Reserve University · R01 · FY2022 · HL

The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)

$760,840
Atul Malhotra · University Of California, San Diego · R01 · FY2024 · HL

Goal Setting to Promote Physical Activity Adherence in Midlife to Reduce Risk of Alzheimer's Disease and Related-Dementias: A Randomized Mechanistic Proof-of-Concept Trial

$760,839
Molly Maxfield · Arizona State University-Tempe Campus · R33 · FY2024 · AG